Fei Lin, Ling Zhou, Jie Li, Zehui Deng, Shaojuan Wang, Longxi He
Journal: Noise & health 2025;27(126):203-209
PMID: 40574290
With the rapid development of industrialisation, noise exposure is becoming increasingly prevalent. The detrimental effects of noise-induced hearing loss (NIHL) have become clinically relevant. Therefore, effective drug therapeutic strategies for NIHL are urgently needed. This article reviewed the pathophysiology and potential molecular mechanisms of NIHL and classified and summarised the drug therapeutic strategies. Drug therapeutic strategies of NIHL can be further studied in agents such as corticosteroids, antioxidants, neurotrophic factors, herbal medicine, magnesium and statins. Given the current research progress, ongoing positive test results and pilot studies may lead to new pharmacological regimens to alleviate NIHL.
Copyright © 2025 Noise & Health.
Full Text Sources:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.